Perspectives

How I will treat my next patient

Is it time to expand the use of PARP inhibitors?

Dr. Alan P. Lyss breaks down new findings presented at the European Society of Medical Oncology Congress on the expanded use of PARP inhibitors in...

Perspectives

Primary CNS lymphoma: R-CHOP hits back

Twenty years after it was concluded that there was no role for R-CHOP in the treatment of primary CNS lymphoma, researchers are reconsidering that...

How I will treat my next patient

The law of unintended consequences

Dr. Alan P. Lyss examines the impact of women’s health clinic closures and excessive radiation doses in some lung cancer screening programs.

Hard Questions

Snapshots of an oncologist

You teach about this disease in your classes and never thought it would happen to you. It started simply enough – you were bruising. Your joints...

Law & Medicine

Labeling of medication warnings

Issuing timely warnings regarding medical products promotes patient safety, and the law appears to place the major onus on the manufacturer.

How I will treat my next patient

Long-term survival in stage IV NSCLC

Dr. Alan P. Lyss dissects the clinical significance of two recent studies that examine the long-term survival of patients with stage IV non–small...

Opinion

Our EHRs have a drug problem

Setting up electronic prescribing of controlled substances in an electronic record can be costly and incredibly time consuming.

Pages